Hazem Saleh

Hazem Saleh is a seasoned business development and commercial strategy leader with extensive experience in the healthcare sector. Currently serving as Group Director and Head of Business Development at Burjeel Holdings since June 2025, Hazem drives revenue growth, patient acquisition, and market expansion. Prior roles include Regional Cardiometabolic Strategy & Commercial Director at Novo Nordisk, where strategic leadership was provided for a $200 million franchise, and Regional Head of Diabetes Business Group at Medtronic. Hazem's background includes various managerial positions at Novo Nordisk and The Janssen Pharmaceutical Companies, along with foundational experience as a Medical Representative at Wyeth Egypt. Educational credentials consist of an MBA from the University of Strathclyde, a Bachelor's in Pharmaceutical Sciences from Cairo University, and various executive management programs.